Founded 1992, world's longest-operating angel syndicate. ~130 members, 11-strong exec team. Invested £161m+ to date; created 3,647 direct jobs. 2025: £41.1m deployed (£12.8m syndicate, £28.4m co-invested). Recent: CSignum (underwater comms, £6m), Neuranics (semiconductors, £6.1m), Calcivis (dental imaging, £3m). Exits: Optoscribe→Intel 2022, Blackford Analysis→Bayer. Co-invests: Scottish Enterprise, other angels, VCs.
Investment Focus
Investment Thesis
Est. 1992, longest continuously operating angel syndicate globally. IP-rich tech & life sciences: software, biopharmaceuticals, bionics. Preferred cheque: £250k-£2m. Scotland-based, B2B, high growth, defendable tech, EIS-eligible. Patient capital: avg 8yr horizon, 5-6 funding rounds. Strong exit returns: £40m to investors over 4yrs. Avoid non-Scottish, consumer, early-stage without IP.
Interested in connecting?
Visit their website or reach out directly.